ProPhase Labs, Inc. company info

CIK 868278
IRS Number 232577138
State of incorporation DE
Business address 621 N. SHADY RETREAT ROAD
None
DOYLESTOWN
PA
18901
Mail address 621 N. SHADY RETREAT ROAD
None
DOYLESTOWN
PA
18901

Short summary

ProPhase Labs, Inc. is a Pennsylvania company, with head office located at 621 N. Shady Retreat Road Doylestown, Pennsylvania 18901. The company achieved a record breaking net income last year - 41.83 million USD. This is -1558.54% higher than one reported in 2016. In 2017 the company owned a total of 34.22 million USD worth of assets, including 31.57 million USD worth of current assets. 2016 was the year when the company amassed the most assets. The company net sales last year amounted to 9.87 million USD. The company allocated 431.00 thousand USD of its income to research and development.

ProPhase Labs, Inc. Income Statement

Name [in Millions USD]2008200920102011201220132014201520162017Trends
Revenue, Net 19.8214.5017.4522.4125.0322.0720.604.219.87
Cost of Goods and Services Sold 8.255.676.178.158.367.891.693.217.92
Gross Profit 11.578.8311.2814.2516.6714.1812.181.001.95
Research and development 1.310.791.091.300.821.321.080.360.43
Operating Expenses 15.5012.4214.0215.3516.2622.0115.764.795.94
Operating Income (Loss) -3.94-3.59-2.74-1.100.42-7.83-3.58-2.66
Interest expense 000.010.010.020.210.05
Other Nonoperating Income (Expense) 0.010.190.05
Income Tax Expense (Benefit) -0.08-0.04000-17.99
Net income -3.84-3.50-2.71-1.090.41-7.83-3.60-2.8741.83

ProPhase Labs, Inc. Balance Sheet

Name [in Millions USD]2008200920102011201220132014201520162017Trends
Cash and cash equivalents 11.9611.168.744.614.067.353.761.1537.283.39
Accounts Receivable, Net, Current 1.160.941.132.341.251.801.841.79
Inventories 1.593.143.293.253.714.351.972.01
Property, Plant and Equipment, Gross 5.926.236.636.947.668.318.21
Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment 3.583.733.984.204.514.925.275.57
Total assets 17.7515.1815.0719.7612.0411.5450.1034.22
Current assets 11.809.189.0013.679.188.4842.2231.57
Accounts payable 0.130.531.031.400.651.370.920.54
Taxes Payable, Current 1.340.01
Total current liabilities 5.796.404.475.953.585.183.471.10
Long-term Debt, Excluding Current Maturities 0.10
Long-term Debt 1.60
Common Stock, Value, Issued 0.010.010.010.010.010.010.010.01
Retained Earnings (Accumulated Deficit) -3.98-7.32-7.22-9.33-16.17-19.2822.6522.19
Accumulated Other Comprehensive Income (Loss), Net of Tax -0.12

ProPhase Labs, Inc. Cash Flow

Name [in Millions USD]2008200920102011201220132014201520162017Trends
Net income -3.84-3.50-2.71-1.090.41-7.83-3.60-2.8741.83
Depreciation 0.360.360.250.240.280.370.430.34
Depreciation and amortization 0.520.360.360.250.240.280.370.43
Deferred Income Tax Expense (Benefit) 0.05-0.900.760.22-2.55-1.48-1.0017.49
Accounts receivable -2.491.22-1.602.19-0.090.52-1.841.77-3.83
Inventories -0.96-0.451.01-0.640.470.771.04-1.60-1.21
Accounts payable -0.11-0.220.400.41-0.29-0.340.321.17-1.59
Net Cash Provided by (Used in) Operating Activities 0.45-3.55-2.11-5.731.14-3.22-3.50-0.47-2.84
Payments to Acquire Property, Plant, and Equipment 0.210.150.300.310.440.310.720.650.21
Payments to Acquire Intangible Assets 0100
Net Cash Provided by (Used in) Investing Activities 0.27-1.15-0.13-0.31-0.44-0.31-0.71-0.6521.77
Net Cash Provided by (Used in) Investing Activities, Continuing Operations -0.13-0.31-0.44-0.31
Proceeds from Issuance of Common Stock 001.070.444.911.56
Payments for Repurchase of Common Stock 16.28
Net Cash Provided by (Used in) Financing Activities 0.130.13-0.451.070.374.812.94-0.10-16.20
Cash and Cash Equivalents, Period Increase (Decrease) 0.84-4.57-2.69-4.971.071.29-1.26-1.222.73